| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB08314736AGB2120942B (en) | 1982-05-27 | 1983-05-27 | Salbutamol compositions | 
| MX9202984AMX9202984A (en) | 1982-05-27 | 1992-06-18 | PHARMACEUTICAL COMPOSITIONS CONTAINING SALBUTAMOL. | 
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB8215502 | 1982-05-27 | ||
| GB08314736AGB2120942B (en) | 1982-05-27 | 1983-05-27 | Salbutamol compositions | 
| Publication Number | Publication Date | 
|---|---|
| GB8314736D0true GB8314736D0 (en) | 1983-07-06 | 
| GB2120942A GB2120942A (en) | 1983-12-14 | 
| GB2120942B GB2120942B (en) | 1985-10-30 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GB08314736AExpiredGB2120942B (en) | 1982-05-27 | 1983-05-27 | Salbutamol compositions | 
| Country | Link | 
|---|---|
| GB (1) | GB2120942B (en) | 
| MX (1) | MX9202984A (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| DE3430809A1 (en)* | 1984-08-22 | 1986-03-06 | Merck Patent Gmbh, 6100 Darmstadt | SUCRALFAT SUSPENSION | 
| FI93924C (en)* | 1991-09-17 | 1995-06-26 | Martti Lauri Antero Marvola | Procedure for the preparation of a drug that can be releasably controlled | 
| CN114159385A (en)* | 2021-09-27 | 2022-03-11 | 北京四环科宝制药股份有限公司 | Pharmaceutical composition containing salbutamol sulfate and preparation method thereof | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| GB1200886A (en)* | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives | 
| Publication number | Publication date | 
|---|---|
| GB2120942A (en) | 1983-12-14 | 
| MX9202984A (en) | 1992-07-01 | 
| GB2120942B (en) | 1985-10-30 | 
| Publication | Publication Date | Title | 
|---|---|---|
| GB8326565D0 (en) | Pharmaceutical compositions | |
| GB8327612D0 (en) | Pharmaceutical compositions | |
| GB2136807B (en) | Pharmaceutical compositions | |
| DE3467703D1 (en) | Pharmaceutical compositions | |
| CY1678A (en) | Pharmaceutical compositions | |
| ZA834074B (en) | Pharmaceutical composition | |
| GB2136806B (en) | Pharmaceutical compositions | |
| ZA833781B (en) | Pharmaceutical compositions | |
| EP0093551A3 (en) | Pharmaceutical composition | |
| CY1503A (en) | Pharmaceutical compositions | |
| GB2118176B (en) | Pharmaceutical compositions | |
| PT77323A (en) | Pharmaceutical compositions | |
| GB2117766B (en) | Pharmaceutical compositions | |
| GB8429749D0 (en) | Pharmaceutical compositions | |
| GB8313814D0 (en) | Pharmaceutical compositions | |
| GB8329700D0 (en) | Anti-haemophilic pharmaceutical composition | |
| DE3377696D1 (en) | Pharmaceutical compositions | |
| US4594359B1 (en) | Pharmaceutical compositions | |
| GB8328896D0 (en) | Pharmaceutical composition | |
| EP0136006A3 (en) | Pharmaceutical compositions | |
| GB2114001B (en) | Nasel pharmaceutical compositions | |
| GB8305028D0 (en) | Pharmaceutical compositions | |
| GB8330810D0 (en) | Pharmaceutical compositions | |
| GB8314736D0 (en) | Pharmaceutical compositions | |
| GB8332653D0 (en) | Pharmaceutical composition | 
| Date | Code | Title | Description | 
|---|---|---|---|
| PE20 | Patent expired after termination of 20 years |